Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 10.6B | 10.1B | 10.3B | 7.9B |
Cost of revenue | 6.4B | 6.0B | 6.0B | 6.0B |
Gross profit | 4.2B | 4.1B | 4.4B | 1.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.4B | 1.1B | 1.4B | -240.2M |
Operating income | 539.2M | 768.5M | 863.2M | 590.5M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 45.4M | 51.3M | 119.0M | 120.1M |
Other income expense | — | — | — | — |
Pretax income | 751.4M | 910.5M | 915.9M | -328.8M |
Tax provision | -744.7M | 247.4M | 249.4M | 65.9M |
Net income | 1.5B | 663.1M | 666.5M | -394.7M |
Basic EPS | — | 4.3 | 4.4 | — |
Diluted EPS | — | 4.3 | 4.4 | — |
Basic average shares | — | 153.0M | 149.2M | — |
Diluted average shares | — | 153.0M | 149.2M | — |
EBITDA | 1.1B | 1.4B | 1.3B | 1.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -11.3M | -14.5M | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |